3 questions for CanChip founder Ghazaleh Madani – »For a rapid change towards personalized cancer treatments medicine, we need a push out of the comfort zone now«
Ghazaleh Madani is the founder of CanChip, a start-up engaged in the development of innovative tumour-on-a-chip technologies at the Potsdam Science Park. The chips produced in Potsdam-Golm serve as the basis for the development of novel cancer drugs and enable efficient and precise drug screening for personalised cancer therapies. In this interview, Ghazaleh Madani discusses…
Read more